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Acetaminophen (APAP) overdose is a major cause of acute liver failure. Peripheral 5-hydroxytryptamine
(serotonin, 5-HT) is a cytoprotective neurotransmitter which is also involved in the hepatic physiological
and pathological process. This study seeks to investigate the mechanisms involved in APAP-induced
hepatotoxicity, as well as the role of 5-HT in the liver’s response to APAP toxicity. We induced APAP
hepatotoxicity in mice either sufficient of serotonin (wild-type mice and TPH1-/- plus 5-
Hydroxytryptophan (5-HTP)) or lacking peripheral serotonin (Tph1-/- and wild-type mice plus
p-chlorophenylalanine (PCPA)).Mice with sufficient 5-HT exposed to acetaminophen have a significantly
lower mortality rate and a better outcome compared with mice deficient of 5-HT. This difference is at least
partially attributable to a decreased level of inflammation, oxidative stress and endoplasmic reticulum (ER)
stress, Glutathione (GSH) depletion, peroxynitrite formation, hepatocyte apoptosis, elevated hepatocyte
proliferation, activation of 5-HT2B receptor, less activated c-Jun NH2-terminal kinase (JNK) and
hypoxia-inducible factor (HIF)-1a in the mice sufficient of 5-HT versus mice deficient of 5-HT. We thus
propose a physiological function of serotonin that serotonin could ameliorate APAP-induced liver injury
mainly through inhibiting hepatocyte apoptosis ER stress and promoting liver regeneration.
A
cetaminophen (N-acetyl-p-aminophenol, APAP), a widely used analgesic and antipyretic drug, is
believed to be safe within therapeutic doses. However, an accidental or an intentional APAP overdose
often causes acute liver failure with highmorbidity and mortality1,2. The underlying mechanism of APAP
hepatotoxicity is thought to be conversion of APAP to N-acetyl-p-benzoquinone imine (NAPQI), which is
mediated bymembers of the cytochrome P450 family, especially CYP2E1.NAPQI can be immediately conjugated
with glutathione (GSH) to form the non-toxic metabolites cysteine3,4. Once the intracellular pool of GSH is
exhausted, NAPQI covalently combines with cellular proteins, which results in mitochondrial dysfunction and
oxidative stress5. This type of covalent binding inactivates important functional proteins, leading to hepatic cell
death and enzymes like alanine aminotransferase (ALT) release into plasma6. Both the intracellular (mitochon-
dria) and extracellular (inflammatory cells) reactive oxygen species (ROS) contribute to the liver injury7,8.
Oxidative stress induces c-Jun NH2-terminal kinase (JNK) activation, which would further promote mitochon-
drial dysfunction and mitochondrial permeability transition, amplify oxidative stress and lead to sustained JNK
activation, and ultimately cause cell death. Previous studies revealed that JNK activation plays a major role in
APAP-induced hepatotoxicity which can be inhibited by genetic depletion or pharmaceutic inhibitor9–11.
Serotonin, as well-known as 5-hydroxytryptamine (5-HT), a small monoaminemolecule primarily known as a
neurotransmitter, is involved in the regulation of various physiologic procedures including cognition, mood,
aggression, mating, feeding, and sleep12. Peripherally, serotoninmediates vascular contraction and relaxation, cell
proliferation, apoptosis, and platelet aggregation. To date, 15 different 5-HT receptor subtypes have been iden-
tified13. Except for its major role in central nervous system, recent studies show that 5-HT plays a crucial role in
liver physiology and pathology. To be specific, serotonin is a double-edged sword which is both a friend and a foe
to the liver14. On the one hand, serotonin expedites liver regeneration after partial hepatectomy in various rodent
models and promotes tissue repair after ischemia/reperfusion injury15,16. It is also beneficial to the stabilization of
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hepatic microcirculation and prevents small-for-size liver graft fail-
ure17. Similarly, serotonin receptor agonists improve the sinusoidal
perfusion of aged liver and restore the deficient liver regeneration in
old mice which shows an effect of age defying18. Besides, serotonin
can also regulate regeneration of the biliary tree by targeting cholan-
giocytes through an autocrine/paracrine signal way19. But, on the
other hand, studies reveal that serotonin contribute to non-alcoholic
fatty liver diseases (NAFLD) in rodent models through its degrada-
tion products, the reactive oxygen species20. Serotonin aggravates
viral hepatitis, and plays a crucial role in the progression of hepatic
fibrosis21,22. Serotonin may also facilitate tumor growth of primary
liver carcinoma like cholangiocarcinoma and hepatocellular carcin-
oma23,24. So far the role of 5-HT in the APAP-induced hepatotoxicity
is still unknown. In this study, we focused on the effect of 5-HT on
the APAP-induced hepatotoxicity and the relevant mechanisms in
mice models.
Methods
Experimental animals. The study was conducted using male TPH1 knockout mice
and wild-type C57BL/6 mice (4–6 weeks, 21–26 g) (Animal Feeding Center of Xi’an
Jiaotong University Health Science Center). The TPH12/2 mice were characterized
elsewhere16,17,25. All mice were housed (5 per cage) in clear, pathogen-free
polycarbonate cages in the animal care facility, and were fed with a standard animal
diet and water ad libitum under controlled temperature conditions with 12 h light-
dark cycles. All animal experiments were performed in accordance with the
guidelines of China Council on Animal Care and Use. All animal procedures carried
out in this study were reviewed, approved, and supervised by the Institutional Animal
Care and Use Committee of the Ethics Committee of Xi’an Jiaotong University
Health Science Center, China. All animals were kept and the experiments were
performed in accordance with the European Community guidelines for the use of
experimental animals (86/609/EEC).
Study design. Mice used in the study were randomly allocated into the following
groups: (1) Normal control group: wild type mice and TPH1 knockout mice were
treated with 0.9% saline solution through intraperitoneal injection (because of the
same results, they served as control group together). (2) WT group: wild type mice
were treated with APAP (suspended in saline solution, in a final volume of 0.25 mL)
through intraperitoneal injection (i.p). (3) WT1PCPCA group: wild type mice were
treated with APAP and p-chlorophenylalanine (PCPA, TPH1-inhibitor, at a dose of
150 mg/kg/day for 3 days by subcutaneous injection before APAP treatment) i.p. as
previously reported25. (4)KO group:TPH1 knockoutmice were treated i.p with APAP
(TPH1, the rate-limiting enzyme for the synthesis of peripheral serotonin).
(5)KO15-HTP group: TPH1knockout mice were treated i.p with APAP and 5-
Hydroxytryptophan (5-HTP, precursor of 5-HT which can reload the 5-HT content,
at a dose of 75 mg/kg/day for 3 days by subcutaneous injection before APAP
administration) as previously reported19. In another set of experiments, animals (n 5
15 for each group) were randomly divided as described above and monitored for
assessing mortality for 5 days after a lethal dose of APAP (600 mg/kg) or saline
administration.
Measurement of liver function. Serum ALT, AST and alkaline phosphate activities,
as well as bilirubin levels were determined by using an Olympus AU5400 Automatic
Biochemical Analyzer (Olympus, Tokyo, Japan) in the Department of Inspection,
The First Affiliated Hospital of Xi’an Jiaotong University26.
Cytokine measurement in murine serum. Levels of serum 5-HT, TNF-a and IL-6
were measured with a commercial ELISA kit following the instructions of the
manufacturer (Dakewe, Shenzhen, China).
Liver enzymatic activity assay. The liver tissue was homogenized, and tissue
myeloperoxidase (MPO), malonaldehyde (MDA), GSH, glutathione peroxidase
(GSH-px) activities were measured using the activity assay kits from NanJing
JianCheng Bioengineering Institute according to the manufacturer’s instructions.
Histological study. Liver samples were excised and fixed in 10% formalin solution
and embedded in paraffin after completion of the routine follow-up. Serial sections of
5-mm thickness were obtained and stained with Hematoxylin&Eosin (H&E) to
evaluate morphology. The results were examined in a blind fashion by two
researchers. For electron microscopy examination, liver tissues were prefixed after
harvesting immediately with 1.5% glutaraldehyde and 0.8% paraformaldehyde
(0.1 mol/L cacodylate buffer) at room temperature and postfixed in an aqueous
solution of 1% OsO4 and 1.5% K4(FeCN)6. Then the specimens were embedded into
Epon by routine procedures. Ultrathin sections (50 nm) were contrasted with lead
citrate and uranyl acetate and studied with a CM100 Transmission Electron
Microscope.
Transferase-mediated dUTP nick end-labeling (TUNEL) assay. Apoptotic cells
were detected by the TUNEL method using an in situ cell detection kit for the
detection and quantification of apoptosis at a single-cell level. Staining of tissue
sections was performed according to the manufacturer’s protocol. Paraffin-
embedded sections were dewaxed in xylene and rehydrated by passing through a
graded series of ethanol solutions, ending with phosphate-buffered saline. Sections
were permeabilized with proteinase K (20 mg/mL in 10 mmol/L Tris-HCl, pH 7.4–
8.0) at 37uC for 15 min. After washing, sections were stained with fluorescent anti-
TdT. Sections were viewed and photographed using standard fluorescentmicroscopic
techniques.
Immunohistochemistry (IHC). IHC analysis was performed with 4-
hydroxynonenal (4-HNE), Nitrotyrosine, TUNEL apoptotic staining, BrdU, Ki-67,
PCNA antibodies and HIF-1a, using methods as previously described27. Mice given
BrdUrd (0.5 mg/ml) in drinking water for 4 days were analyzed
immunohistochemically for liver nuclear-labeling indices.
RNA isolation and quantitative reverse transcription–polymerase chain reaction
(qRT–PCR) analysis. Liver tissue samples from each group were snap-frozen in
liquid nitrogen and stored at 270uC until use. Total RNA was isolated from cells
using the RNAfast200 Kit (Fastagen Biotech, Shanghai, China). Reverse transcription
was performed using the PrimeScript RT reagent Kit (TaKaRa Biotechnology, Dalian,
China). ThemRNAexpressionwas assayed in triplicate and normalized to theb-actin
mRNA expression. The relative levels were calculated using the Comparative-Ct
Method (DDCt method). The primers used in the study were listed in Supplementary
Table 1.
Western blotting. The monoclonal antibodies used in this research were purchased
from Neomarker, Santacruz, Kangcheng for Sigma and Cell signaling. Protein
concentration was determined by BCA method. Western blotting was performed as
previously described28.
Statistical analysis. The survival and mortality rates are expressed as percentages.
Themeasurement data are expressed asmean6 standard deviation (SD). Differences
between experimental and control groups were assessed by either t test or the analysis
of variance (ANOVA), as applicable, using SPSS 18.0 (SPSS, 165 Inc.). A p-value of
less than 0.05 was considered statistically significant.
Results
TPH1-/- mice are more susceptible to acetaminophen-induced
hepatotoxicity. Acetaminophen produced a dose-dependent hepa-
totoxicity. Liver injury was aggravated as the acetaminophen dose
increases. TPH1 null mice were more susceptible than wild typemice
to acetaminophen-induced hepatotoxicity at the doses of 250–
500 mg/kg, as evidenced by marked increases in serum activities of
ALT and AST (Figure 1A). In parallel with serum enzyme activities,
more severe necrosis was observed in TPH1 null mice than in wild
type mice after acetaminophen administration (Figure 1B).
Contemporarily, the depletion of GSH was more rapid in TPH1
knockout mice. (Figure 1C). Then we studied the time course for
the effect of APAP on hepatotoxicity inWT and KOmice. Mice were
administered 300 mg/kg APAP and sacrificed at 0, 1, 4, 6, 8 and
24 hours after APAP administration. The development of hepato-
toxicity was evaluated with the serum levels of ALT and AST and the
histopathological evaluation. The time course of the APAP-induced
increases in serumALT andAST is shown in Figure 2. InWT andKO
mice, ALT andAST levels were significantly increased by 4 hours. By
comparison, the serum ALT levels in the WT mice paralleled those
observed in the KO mice but seemed delayed. The serum ALT levels
at 6, 8 and 24 hours in the WT mice were significantly lower than
those in the KO mice. AST levels in KO mice were significantly
higher than those in WT mice at 8 and 24 hours (Figure 2A). In
parallel with serum enzyme activities, differences of time-dependent
necrosis and hepatic GSH content were also observed in KO andWT
mice (Figure 2B and 2C).
Serotonin depletion aggravates APAP-induced liver injury in wild
type mice and serotonin reloading mitigates hepatotoxicity in
TPH1-/- mice. To further validate the role of 5-HT in APAP-
induced liver injury, wild type mice were treated with the PCPA
before APAP challenge, which has been shown to be a powerful
TPH1 enzyme inhibitor25,29. As demonstrated in Figure 3, PCPA
significantly decreased plasma 5-HT levels in wild type mice,
which was accompanied by elevations in AST, ALT levels and liver
necrosis, and the reduction of 5-day’s survival. Together, these
www.nature.com/scientificreports
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findings show that genetic and pharmacologic inhibition of TPH1
significantly aggravates APAP-induced liver injury. Meanwhile, to
substantiate the protective role of serotonin in experimental APAP-
induced liver injury, we reloaded Tph1-/- mice with serotonin by
injecting its precursor 5-HTP 3 days beforehand. Representative
markers of liver injury (AST and ALT) reduced in the serotonin-
supplemented group at 24 hours after APAP administration when
compared with the KO groups (Figure 3A, 3B, 3C, 3D, 3E and 3F).
Taken together, serotonin can also decrease the necrosis region of the
liver and improve the 5-day’s survival.
Figure 1 | Dose-response for the effect of APAP on serum ALT and AST, histological examination, liver index and hepatic GSH in Wild-type and
TPH1-/- mice.Mice (n5 6) were given an i.p. injection of acetaminophen (50–400 mg/kg for 24 hours). The liver injury in survivingmice wasmeasured
by (A) serum ALT and AST, and Liver tissue were obtained at 24 hours after APAP administration at the dose of 150, 300 and 500 mg/kg. (B) H&E
staining, (C) liver index, hepatic necrosis area, and hepatic GSH content were adopted to evaluate the different hepatotoxicity between Wild-type and
TPH1-/- mice. The data are presented as mean 6 S.D. *P , .0.05 vs WT group, **P , .0.01 vs WT group.
Figure 2 | Time course for the effect of APAP on serum ALT and AST, histological examination, liver index and hepatic GSH in Wild-type and
TPH1-/- mice.Mice (n 5 6) were treated with a 300 mg/kg dose of APAP and sacrificed at the indicated times, and serum and liver were collected. The 0
time is the mice in bothWT and KO receiving no APAP administration. (A) Serum ALT and AST levels. Liver tissue were obtained at 1, 8, and 24 hours
after a dose of 300 mg/kg APAP administration. (B)H&E staining, (C) liver index, hepatic necrosis area and hepatic GSH levels in liver were used to assess
the difference between Wild-type and TPH1-/- mice. The data are presented as mean 6 S.D. *P , .0.05 vs WT group, **P , .0.01 vs WT group.
www.nature.com/scientificreports
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Serotonin decreases cytokines transcription, oxidative stress and
APAP-adducts formation in the liver. To assess whether cytokines
concentrations induced by APAP in the serum are influenced by 5-
HT levels, we measured TNF-a and IL-6 concentrations in serum
24 hours following APAP administration. The result showed that
serum levels of TNF-a and IL-6 in the WT and KO15-HTP groups
were significantly lower than the mice deficient of 5-HT
(Figure 4A). Meanwhile, when detecting the mRNA levels of
TNF-a and IL-6 in the liver tissues, we found that TNF-a and IL-
6 had significantly higher transcriptional levels in the WT1PCPA
and KO groups (Figure 4B). Meanwhile, the present study showed
that APAP significantly enhanced oxidative stress (indicated by
MPO and MDA levels and 4-HNE expression) in the WT1PCPA
and KO groups (Figure 4C and 4E). Simultaneously, glutathione
(GSH), not only an indicator of oxidative stress, but also an
important role in detoxification of the acetaminophen metabolite
NAPQI, was determined to ascertain whether there was a difference
in its depletion in the APAP-treated mice. Treatment of wild mice
with PCPA or TPH1 knockout produced a significant reduction of
GSH and GSH-px levels in liver after APAP administration when
compared with the WT or KO15-HTP groups (Figure 4D). It is
well established that an APAP overdose induces peroxynitrite
formation as indicated by the appearance of NT protein adducts
in centrilobular hepatocytes. To investigate whether 5-HT can
influence peroxynitrite formation, NT protein adducts were
evaluated in the four groups 24 hours after APAP administration.
The results showed that a more extensive NT staining of
centrilobular hepatocytes was observed in the WT1PCPA and
KO groups (Figure 4F).
Serotonin inhibits APAP-challenged hepatocyte apoptosis in the
liver. Acetaminophen toxicity is often associated with hepatic
centrilobular necrosis while hepatocyte apoptosis is a controversial
existence. To further analyze whether apoptosis would coexist with
necrosis in APAP-induced hepatotoxicity, we detected APAP-
induced apoptosis by TUNEL staining and investigated the
possible role of Bcl-2 family proteins and caspase-3 under this
pathophysiological condition. TUNEL staining showed that liver
sections from mice in WT1PCPA and KO groups were more
positively stained than mice in the WT and KO15-HTP groups
(Figure 3G). Contemporarily, we carried out western blot analysis
of phosphorylation Bcl-2 proteins (Bcl-2 and Bcl-xL) and caspase-3
and found an apparent up-regulation in p-Bcl-2 and p-Bcl-xL
expression in APAP-exposed mice. However, mice sufficient with
5-HT effectively show reduced levels of those. On the other hand,
APAP-exposure increases neither caspase-3 nor cleaved-caspase-3
expression which was consistent with previous research that caspase-
3 might not play an effect in the APAP-induced liver injury30
(Figure 5A and 5B).
Serotonin promoted endoplasmic reticulum (ER) and inhibited
ER stress after APAP challenge. The endoplasmic reticulum (ER) is
an important intracellular organelle that carries out multiple
physiological functions. Previous studies showed that ER stress was
induced during the APAP hepatotoxicity31. So, we detected the ER
stress in the current study to determine whether ER stress can be
affected by 5-HT. 24 hours after APAP administration (300 mg/kg),
mice were sacrificed and the liver tissue were obtained to assess the
ER stress and mitochondria injury. Subsequent analysis by electron
Figure 3 | Depletion of 5-HT in wild type mice by inhibition of TPH1 aggravating APAP hepatotoxicity while reloading 5-HT in TPH1-/- mice
by 5-HTP alleviating liver injury. Four groups including sufficient 5-HT (WT and KO15-HTP groups) and deficient 5-HT (WT1PCPA and KO
groups) are recruited to study the role of 5-HT in APAP hepatotoxicity. Mice (n 5 6) were given an i.p. injection of acetaminophen (300 mg/kg for
24 hours), and serum and liver tissues were collected. (A), the concentration of 5-HT in the four groups. (B), Liver index of the mice after APAP
administration from the four groups. (C, D), ALT andAST levels in serum. (E), Kaplan-Meier survival curve formice (n5 15) in the four groups during 5
days after a single lethal dose of APAP (600 mg/kg). (F), the HE staining of liver sections from four groups and relative percent of necrosis area. (G), the
TUNEL staining of hepatocyte apoptosis and corresponding percentage of positive cells. *P, .0.05 vsWT group, **P, .0.01 vsWT group, {P, .0.05 vs
TPH1 knockout group, {{P , .0.01 vs TPH1 knockout group.
www.nature.com/scientificreports
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microscopy revealed APAP induced ER tumidness, hyperplasia and
dissolvent. It could also induce megamitochondria, mitochondria
pyknosis, tumidness and flocculent degeneration. These injuries
could be alleviated in the wild-type mice when compared with
TPH1-/- mice (Figure 6A). Meanwhile, RT-PCR and western bolt
analysis revealed that the ER stress related genes such as GRP78,
ATF4, CHOP, XBP1 were more highly expressed in the mice e lack
of 5-HT (Figure 6B and 6C).
Serotonin promoted hepatocyte proliferation in vivo after APAP
challenge.As the former study showed that serotonin could promote
the liver regeneration and hepatocyte proliferation after partial
hepatectomy and hepatic ischemia/reperfusion injury15,16, we hypo-
thesized that serotonin might also increase hepatocyte proliferation
after the APAP overdose. To test this hypothesis, mice were
sacrificed at 72 hours after APAP administration (300 mg/kg), and
livers were harvested for BrdU, Ki67 and PCNA staining. The tissue
fromWT1PCPA and KO groups displayed quite a little increase in
the number of positive staining hepatocytes, while 5-HT sufficiency
can facilitate hepatocyte proliferation (Figure 7A,7B,7C and 7D).
Meanwhile, PCNA and Cyclin D1Western blot data indicated that
mice lack of 5-HT experienced a lower level of liver regeneration after
the APAP overdose and exhibited significantly lower cell prolifera-
tion at 72 hours after APAP administration. To investigate the
molecular mechanisms underlying the improvement of liver rege-
neration, we examined whether 5-HT modulated liver proliferation
signaling events mainly through the transcription factor STAT3, a
key protein in the hepatocyte proliferation by western blot
analysis32,33. Activated STAT3 was higher expressed in the mice
with 5-HT when compared with mice lack of 5-HT, which hinted
that 5-HT might promote liver regeneration partially by the
activation of STAT3. (Figure 7E and 7F)
Serotonin inhibited APAP-induced phosphorylation of JNK and
activation of CYP2E1. 5-HT receptors are the direct target of 5-HT.
So we used RT-PCR to detect the specific 5-HT receptor that was
involved in the APAP-induced hepatotoxicity. The result showed
that 5-HT2B receptor was more expressed compared with others,
which was also confirmed by the Western Blot analysis (Figure 8A).
It was also very interesting that previous studies showing activation
of 5-HT2B could promote hepatocyte proliferation in mice, which
was in accordance with the result in our study17. It is known that JNK
activation is mediated by oxidative stress and plays pathogenic roles
in a diverse array of cellular programmes, including cell diffe-
rentiation, movement, proliferation and death34. To investigate the
mechanisms for APAP-induced necrotic hepatocytes death, we
studied the JNK involved in the signal transduction in the hepatic
tissues. Western blot analyses showed a significant enhancement in
the expression of phospho-JNK after APAP challenge, and sufficient
5-HT could reduce its expression, whereas no significant change was
found in the expression of total JNK. Furthermore, we investigated
the effect of APAP on CYP2E1 protein level and found that CYP2E1
protein level was increased in the APAP-induced liver tissue while 5-
HT could normalize these changes and maintain the normal
Figure 4 | 5-HTmitigates inflammation, oxidative stress and nitrotyrosine formation in the liver after APAP administration. At 24 hours after APAP
challenge (300 mg/kg), serum and liver samples were collected from experimental groups to detect the levels of inflammation and oxidative stress.
(A). Serum levels of TNF-a and IL-6, (B). The transcriptional levels of TNF-a and IL-6 in the liver tissue, (C). The MDA and MPO levels in the liver,
(D). The levels of antioxidants (GSH and GSH-px), (E).The immumohistochemical staining of 4-Hydroxynonenal (4-HNE) and relative staining score,
(F). The formation of peroxynitrite detected by immumohistochemical staining of nitrotyrosine protein adducts and relative staining score. n 5 6,
*P , .0.05 vs WT group, **P , .0.01 vs WT group, {P , .0.05 vs TPH1 knockout group, {{P , .0.01 vs TPH1 knockout group.
www.nature.com/scientificreports
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physiology of the organs (Figure 8B and 8C).Meanwhile, we detected
the HIF-1a, a key protein in the mechanism of APAP-induced liver
injury35 and found that 5-HT could decrease the expression of HIF-
1a by which 5-HT contributed to relieve of APAP-induced
hepatotoxicity (Figure 8D and 8E).
Discussion
Liver is the major site for drug metabolism and elimination, which
makes it susceptible to drug toxicity36. Acetaminophen, the most
commonly used analgesic drug, is believed to be safe within thera-
peutic doses. However, an APAP overdose always produces a cen-
trilobular hepatic necrosis which is the main cause of acute liver
failure in the western world2. Though decades of studies have been
launched, the mechanisms of APAP-induced liver injury are not
completely known. 5-HT is a small monoamine molecule primarily
known for its role as a neurotransmitter. Previous studies showed
that peripheral 5-HT could play an important role in the hepatic
physiological and pathological process37,38. This experiment was
designed to study the role of 5-HT in acetaminophen-induced hepa-
totoxicity. We employed mice lacking Tph1, the rate-limiting
enzyme for the synthesis of peripheral serotonin, to sort as the 5-
HT deficient group.We also used PCPA, an inhibitor of TPH1 as the
pharmacological intervention to induce the 5-HT deficiency in the
wild type mice. Meanwhile, we used 5-HTP, the precursor of 5-HT,
to replenish the 5-HT deficiency in the TPH1-/-mice. Based on both
genetic and pharmacological methods, we recruited four major
groups, including two rich of 5-HT groups (WT and KO15-HTP
groups) and two deficient of 5-HT groups (WT1PCPA and KO
Figure 5 | 5-HT inhibits the hepatocyte apoptosis mainly by the suppression of BCL-2 proteins phosphorylation. 24 hours after APAP challenge
(300 mg/kg), liver samples were collected and proteins were extracted to detect the hepatocyte apoptosis in the APAP hepatotoxicity by western blot
analysis. (A, B). Bcl-2, Bcl-XL and caspase-3 protein levels. b-actin was used as an internal control. n 5 6, *P, .0.05 vs WT group, **P, .0.01 vs WT
group, {P, .0.05 vsTPH1 knockout group, {{P, .0.01 vsTPH1 knockout group. The gels have been run under the same experimental conditions and the
cropped blots images are shown in the figure and the full-length blots are presented in Supplementary Figure S1.
Figure 6 | 5-HT protects the organelles and inhibition of the endoplasmic reticulum (ER) stress after APAP challenge. 24 hours after APAP challenge
(300 mg/kg), liver samples were collected to evaluate the ER stress. (A). Representative electron microscopy of ER tumidness, hyperplasia and dissolved,
and hepatocyte megamitochondria in the liver tissue after APAP administration. (B). The ER stress associated protein levels showed by western Blot
analysis. (C). The transcription and expression levels of ER stress associated gene levels. b-actin was used as an internal control. n 5 6, *P, .0.05 vs WT
group, **P , .0.01 vs WT group, {P , .0.05 vs TPH1 knockout group, {{P , .0.01 vs TPH1 knockout group. The gels have been run under the same
experimental conditions and the cropped blots images are shown in the figure and the full-length blots are presented in Supplementary Figure S1.
www.nature.com/scientificreports
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groups), to ensure the reliability of the experimental results. Our data
showed that depletion of 5-HT using genetic and pharmacologic
inhibition of TPH1 resulted in an increased APAP-induced liver
injury and a slower recovery. In contrast, supplementation of 5-
HT with 5-HTP in TPH1-/- mice resulted in a delayed initiation of
liver injury and an accelerated recovery after APAP treatment. Taken
together, our data indicate that 5-HT can protect against APAP-
induced liver injury.
After APAP administration, liver injury was detected in both KO
and WT mice. The hepatotoxicity differences between the KO and
WT mice were in a time and dose dependent manner. These differ-
ences were also observed in the histopathological evaluation of tox-
icity. Meanwhile, the depletion of glutathione and arylation of
proteins by acetaminophen are important events leading to acetami-
nophen hepatotoxicity. In the present study, TPH1 null mice were
more susceptible to acetaminophen-induced glutathione depletion
Figure 7 | 5-HT facilitates hepatocyte proliferation after APAP challenge. 72 hours after APAP administration (300 mg/kg), liver samples were
collected to evaluate the effect of 5-HT on the liver regeneration. (A). Representative immunohistochemistry staining of BrdU, Ki67 and PCNA in the
liver. (B–D). The quantization of hepatocyte proliferation was launched by calculating the positive cells in a microscopic vision. (E, F) The protein levels
of STAT3, Cyclin D1 and PCNA, which were associated with hepatocyte proliferation, were showed by western blot analysis. b-actin was used as an
internal control. n5 6, *P, .0.05 vsWT group, **P, .0.01 vsWT group, {P, .0.05 vsTPH1 knockout group, {{P, .0.01 vsTPH1 knockout group. The
gels have been run under the same experimental conditions and the cropped blots images are shown in the figure and the full-length blots are presented in
Supplementary Figure S1.
www.nature.com/scientificreports
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compared with the WT mice. Acetaminophen-induced hepatotoxi-
city is thought to be mediated by a cytochrome P-450-generated
intermediate, NAPQI30. Therefore, we determined whether TPH1
null mice had an altered metabolism of acetaminophen. Our results
on hepatic CYP2E1 analysis using western blot indicate that 5-HT
could influence the metabolism of APAP mainly by decreasing the
hepatic CYP2E1 expression. Simultaneously, an APAP overdose
induces peroxynitrite formation as indicated by the appearance of
NT protein adducts in centrilobular hepatocytes39,40. To investigate
whether 5-HT can affect peroxynitrite formation, NT protein
adducts were evaluated by immunohistochemistry. Amore extensive
NT staining of centrilobular hepatocytes was observed in the
WT1PCPA and KO group when compared with the WT and
KO15-HTP mice. Oxidative damage has been proposed as a con-
tributing mechanism of acetaminophen hepatotoxicity41. Oxidative
stress occurs in cells when there is a disruption of cellular redox
balance42. Acetaminophen-induced oxidative stress results in lipid
peroxidation, oxidation of protein thiols, mitochondrial injury,
Figure 8 | 5-HT inhibits the activation of JNK to decrease the HIF-1a expression mainly by 5-HT2B receptor. To investigate the potential mechanism
involved in the 5-HT protecting APAP hepatotoxicity, liver mRNAs and proteins were extracted to detect potential proteins 24 hours after APAP
administration (300 mg/kg). (A) RT-PCR was performed to seek the possible 5-HT receptors, and the results showed that 5-HT2B was the target protein
which was also confirmed by western blot analysis. (B, C)Western blot analysis of CYP2E1, p-JNK, Total-JNK, 5-HT2B receptor andHIF-1a. b-actin was
used as an internal control. (D, E) The immumohistochemical staining of HIF-1a and relative staining score. n5 6, *P, .0.05 vsWT group, **P, .0.01
vsWT group, {P, .0.05 vs TPH1 knockout group, {{P, .0.01 vs TPH1 knockout group. The gels have been run under the same experimental conditions
and the cropped blots images are shown in the figure and the full-length blots are presented in Supplementary Figure S1.
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altered calcium homeostasis, and DNA damage43. In the present
study, TPH1 null mice were more susceptible than controls to acet-
aminophen-andNAPQI-induced lipid peroxidation, as evidenced by
increased MDA and MPO levels, and reduced GSH and GSH-px in
the liver tissues which were also important antioxidant enzymes. The
immunohistochemical localization of lipid peroxidation adducts (4-
HNE) at early time-points correlated with necrosis of hepatocytes
around the central zone. All these data suggested that the greater
susceptibility of TPH1 null mice might be partially due to the
increased oxidative damage produced by acetaminophen.
The role of apoptosis in acetaminophen induced liver injury is
controversial44,45. It is generally accepted that the ultimate form of
hepatic damage caused by acetaminophen is necrosis5. But, accord-
ing to the latest research, researchers tend to agree with its exist-
ence46,47. During APAP intoxication in the mouse, toxic ROS are
generated which can cause apoptotic cell death including JNK activa-
tion10. Both in vivo and in vitro, acetaminophen can induce apoptosis
by triggering the release of mitochondrial cytochrome-c and activ-
ating the apoptotic pathway48,49. Several investigators have suggested
that the way of cell death induced by acetaminophen may be related
to the overall acetaminophen tissue concentrations and intracellular
concentrations of ATP50. So, in this study, we examined whether
apoptosis contributes to the induction of acute liver failure caused
by APAP and whether 5-HT can affect this pathological process.
According to the results of the research, two anti-apoptotic proteins
of the Bcl-2 family (Bcl-2 and Bcl-xL) could be phosphorylated by p-
JNK. But sufficient 5-HT could decrease its expression along with
JNK activation. It has also been reported that caspase inhibitors
protect liver from APAP-induced injury, suggesting that apoptosis
plays a vital role in initiating the events that lead to hepatic damage,
but APAP does not activate execution caspases-3 and -751,52. So we
also investigated the role of caspase-3 after APAP administration and
found that caspase-3 was not activated in our experiments. These
data suggested that the protection of 5-HT might be partially due to
the inhibition of apoptosis of hepatic cells mainly by suppression of
Bcl-2 proteins phosphorylation.
Endoplasmic reticulum is an important intracellular organelle that
carries out multiple physiological functions such as protein folding,
posttranslational modifications, biosynthesis of fatty acids and ster-
ols, detoxification of xenobiotics, and the storage of intracellular
calcium53. It is also important in drug metabolism, as most phase I
enzymes including cytochrome P450 oxidases and some phase II
enzymes localize to the ER54. Hepatocytes in the liver contain abund-
ant ER, which endows the liver with the capacity to engage in lipid
and drug metabolism as well as the production of plasma proteins.
ER stress occurs when the amount of protein entering the ER exceeds
its folding capacity. Previous studies showed that ER stress in the
liver could be induced after APAP administration which contributes
to the liver injury. Uzi D et al found that inhibition of CHOP, a key
protein of ER stress, could protect liver from APAP hepatotoxicity31.
So,we firstly study the change of hepatocellular subcellular structure
by electron microscope. Massive ER swelling, hyperplasia and dila-
tion could be observed in the liver after APAP administration.
Meanwhile, real-time PCR and western blot showed that the ER
stress could be induced by APAP. And 5-HT could stabilize the
structure of organelles and inhibit the ER stress which had the cyto-
protection effect as previous studies showed.
Liver regeneration is a vital process for survival after a toxic insult.
Regeneration ensures the replacement of necrotic cells and the full
recovery of organ function55. Several studies have demonstrated that
compensatory liver regeneration after APAP-induced liver injury is a
critical determinant of final outcome of APAP overdose56–58. The
exposure to growth factors such as hepatocyte growth factor results
in the expression of cell cycle proteins. The induction of Cyclin D1 is
the marker for cell cycle (G1 phase) progression in hepatocytes33,59.
In current investigation, our western blot data showed that a higher
level of 5-HTmarkedly increased the level of Cyclin D1 in the APAP
challenged liver tissue. These changes in Cyclin D1 expression were
associated with decreased serum ALT/AST and improved liver
regeneration in wild type and TPH1-/- plus 5-HTP mice receiving
APAP, suggesting that 5-HT likely facilitates activation of CyclinD1-
mediated regeneration pathways. Our data suggest that 5-HT is an
Figure 9 | Schematic representation of the proposed role of 5-HT in APAP-induced hepatic injury. After administration into the hepatocytes, APAP is
first metabolized by the CYP2E1 and generates the NAPQI, which binds with GSH and also increases ROS and RNS formation to initiate the ER stress
which involved in GRP78 and CHOP activation. Increased ROS leads to the JNK phosphorylation to damage the mitochondria, which also promotes the
phosphorylation of BCL-2 proteins to induce the apoptosis. Meanwhile, inflammatory factors and HIF-1a can be induced with the oxidative stress.
During the hepatic self-repair stage, IL-6/STAT3 pathway can be initiated to promote the cell mitosis and facilitate the liver regeneration. In the present
study, we prove that 5-HT can reduce APAP hepatotoxicity by inhibiting APAP metabolism, ROS and RNS formation and promoting the hepatocyte
proliferation.
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important factor that promotes hepatocyte regeneration after the
APAP overdose. Investigators have shown similar findings in a nor-
mothermic ischemia/reperfusion model of injury. Nocito A and
others demonstrated that TPH1 knock-out mice had significantly
less severe liver injury after ischemia/reperfusion, related to the
accelerated hepatocyte proliferation in the knock-out mice16.
Similarly, Lesurtel M and colleagues also demonstrated that sero-
tonin promoted liver regeneration after partial hepatectomy which
was mediated by 5-HT2A and 2B subtype serotonin receptors15.
Meanwhile, Tian YH et al found that serotonin could protects
small-for-size liver grafts from injury and prevents microcirculation
and regeneration through its activation on receptor-2B17. These find-
ings are similar to ours in that the 5-HT confers protection against a
hepatic injury by promoting the hepatocyte proliferation and liver
regeneration by the activation of 5-HT 2B receptor.
JNK is activated during oxidative stress and plays a central role in
APAP-induced hepatotoxicity60. Hepatic JNK activation is a critical
step in the intra-cellular signaling involved in APAP-induced liver
injury10,61. Our data show that 5-HT depletion results in a rapid
activation of JNK and that the appropriate supplementation results
in a decreased activation of JNK compared with control mice. These
data indicate that 5-HT may suppress JNK activation during APAP-
induced liver injury. But, whether 5-HTdirectly affect JNK activation
or induce this effect via an upstream regulator is not known. 5-HT is
known to signal viamultiple 5-HT receptor pathways in the liver. It is
possible that 5-HT may use one of these pathways to suppress JNK
signaling after APAP-induced liver injury. Meanwhile, HIF-1a was
an important protein associated with JNK signaling which was also a
key protein in the pathological process of APAP-induced liver injury.
HIF-regulated genes include plasminogen activator inhibitor-1
(PAI-1), cell death proteins such as BNIP3 and Nix, which can all
contribute to the liver injury35. According to the study, 5-HT may
decrease the expression of HIF-1a to protect APAP hepatotoxicity.
In conclusion, we describe a novel physiological role for endogen-
ous serotonin in the protection from APAP-induced liver injury
(Figure 9). Considering the pleiotropic effects of serotonin in various
physiological processes, we investigated a number of potential
mechanisms that might underlie the protection effect of 5-HT.
This protect effect of 5-HT on APAP hepatotoxicity was at least
partially attributable to a significantly decreased inflammation, oxid-
ative stress, GSH depletion, peroxynitrite formation, hepatocyte
apoptosis and ER stress, elevated hepatocyte proliferation, activation
of 5-HT2B receptor and less activated JNK and HIF-1a.
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